Tissue Regenix Group (FRA:LSW) OCF Yield %: -8.36 (As of Jun. 27, 2026)


FRA:LSW Tissue Regenix Group PLC FRA:LSW
10 GF Score
Price €0.07
GF Value €0.84
! 5 Warning Signs
View Full Analysis

What is Tissue Regenix Group OCF Yield %?

Tissue Regenix Group FRA:LSW 10 OCF Yield % is -8.36 as of Jun. 27, 2026. GuruFocus rates FRA:LSW with a GF Score™ of 10/100 and a GF Value™ of €0.84. The stock has 5 warning signs investors should review.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Tissue Regenix Group's Trailing 12-Month Cash Flow from Operations is €-0.42 Mil, and Market Cap is €4.99 Mil. Therefore, Tissue Regenix Group's OCF Yield % for today is -8.36%.

The historical rank and industry rank for Tissue Regenix Group's OCF Yield % or its related term are showing as below:

FRA:LSW' s OCF Yield % Range Over the Past 10 Years
Min: -34.9   Med: -3.47   Max: 2.38
Current: -8.36

During the past 13 years, the highest OCF Yield % of Tissue Regenix Group was 2.38%. The lowest was -34.90%. And the median was -3.47%.

FRA:LSW's OCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -8.48 vs FRA:LSW: -8.36

Tissue Regenix Group's OCF Margin % for the quarter that ended in Jun. 2025 was %.

Tissue Regenix Group OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Tissue Regenix Group OCF Yield % Related Terms

Tissue Regenix Group OCF Yield % Historical Data

* Premium members only.

The historical data trend for Tissue Regenix Group's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tissue Regenix Group OCF Yield % Chart

Tissue Regenix Group Annual Data
Trend Jan15 Jan16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -3.86 2.38 -3.27

Tissue Regenix Group Semi-Annual Data
Jul15 Jan16 Jul16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.22 7.95 -4.97 -1.01 -1.62

FRA:LSW vs VRTX, REGN, ALNY: OCF Yield % Comparison

For the Biotechnology subindustry, Tissue Regenix Group's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tissue Regenix Group OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tissue Regenix Group's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Tissue Regenix Group's OCF Yield % falls into.


FRA:LSW
10GF Score
Tissue Regenix Group PLC FRA:LSW
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tissue Regenix Group OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Tissue Regenix Group's OCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-1.561 / 47.72745
=-3.27%

Tissue Regenix Group's annualized OCF Yield % for the quarter that ended in Jun. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-0.175 * 2 / 21.65544
=-1.62%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -8.36 mean?
Tissue Regenix Group (FRA:LSW) has a OCF Yield % of -8.36 as of Jun. 27, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Tissue Regenix Group and its competitors.
Is Tissue Regenix Group's OCF Yield % too high?
Tissue Regenix Group's current OCF Yield % is -8.36. Overall, Tissue Regenix Group has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Tissue Regenix Group's OCF Yield % compare to VRTX and REGN?
Tissue Regenix Group's OCF Yield % of -8.36 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Tissue Regenix Group and its competitors. Tissue Regenix Group's current OCF Yield % is -8.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tissue Regenix Group stock overvalued right now?
Tissue Regenix Group (FRA:LSW) has a current OCF Yield % of -8.36. The stock's GF Value™ is €0.84, compared to a current price of €0.07 — trading 91.7% below its estimated fair value. The current OCF Yield % is -8.36. Tissue Regenix Group's overall GF Score™ is 10/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Tissue Regenix Group (FRA:LSW), the current OCF Yield % is -8.36 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tissue Regenix Group (FRA:LSW) Overvalued in 2026?

Based on GuruFocus' analysis, Tissue Regenix Group stock appears to be undervalued. The current stock price of €0.07 is trading 91.7% below its estimated GF Value™ of €0.84.

Key valuation signals for FRA:LSW:

  • OCF Yield %: -8.36
  • GF Value™: €0.84 vs. price of €0.07 (91.7% below fair value)
  • GF Score™: 10/100 with 5 warning signs

No single metric tells the full story. See the FRA:LSW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tissue Regenix Group Business Description

Address Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY
Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.
10GF Score

Get the complete analysis for FRA:LSW

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.07
Price
€0.84
GF Value